Enhancement of Human Natural Killer Cytotoxic Activity by Vitamin C in Pure and Augmented Formulations

References

• Barnes MJ, K odicek E. Biological hydroxylations and ascorbic acid w ith special regard to collagen m etabolism. V itam in Horm 1972; 30: 1–43.
   Google Scholar
• Thom as TN, Zem p JW. Inhibitio n of dopamine sensitive adenylate cyclase from rat brain striatal hom ogenates by ascorbic acid. J Neurochem 1977; 28: 663–5.
   Google Scholar
• Dogkw itz E, W alsch S, Dubberstein M, W inter J. A scorbic acid and cytochrom es. Ann N Y A cad Sci 1975; 258: 201–8.
   Google Scholar
• Henson DE, Block G, Levine M. A scorbic acid: biologic functions and relation to cancer. J Nat Cancer Inst 1991; 83: 547–50.
   PubMed Web of Science ®Google Scholar
• Chan W C, Fong YY. A scorbic acid prevents liver tum or production by am inopyrine and nitrite in the rat. Int J Cancer 1977; 20: 268–70.
   PubMedGoogle Scholar
• Cameron E, Pauling L. Supplem ental ascorbate in the supportive treatment of cancer; prolongation of survival tim es in terminal hum an cancer. Proc N atl Acad Sci USA 1976; 73: 3685–9.
   PubMed Web of Science ®Google Scholar
• Edgar JA. Ascorbic acid and biological alkylating agents. N ature Lond 1974; 248: 136–7.
   PubMedGoogle Scholar
• Kamm JJ, Dashman T, Conney AH, Burns JJ. Effect of ascorbic acid on amine-nitrite toxicity. Ann NY Acad Sci 1975; 258: 169–73.
   PubMedGoogle Scholar
• Schlegel JU. Proposed uses of ascorbic acid in prevention of bladder carcinoma. Ann NY A cad Sci 1975; 258: 432–6.
   PubMed Web of Science ®Google Scholar
• Raineri R, W eisburger JH. Reduction of gastric carcinogens w ith ascorbic acid. A nn NY A cad Sci 1975; 258: 181–8.
   Google Scholar
• Howe, JGR, Hirohata T, Hislop TG, et al. Dietary factors and the risk of breast cancer: combined analysis of 12 case-controlled studies. J Natl Cancer Inst 1990; 82: 561–9.
   PubMed Web of Science ®Google Scholar
• Buiatti E, Palli D, Decarli A, et al. A case-controlled study of gastric cancer and diet in Italy: II Association w ith nutrients. Int J Cancer, 1990; 45: 896–901.
   PubMed Web of Science ®Google Scholar
• Duchesne J, Gilles R, Mosora F. Effet de substances anti-oxydantes sue le taux de radicaux libres organiques naturellem ent present dans le diaphragm e du rat C.R. hebd. Seanc Acad Sci, Paris 1975; 281: 945–7.
   Google Scholar
• Stankova L, Rigas D A, K eown P, Bigley R. Leucocyte ascorbate and glutathione: potential capacity for inactivating oxidants and free radicals. J Reticuloendoth Soc. 1977; 21: 97–102.
   Google Scholar
• Slaga TJ, Bracken W M. The effects of antioxidants on skin tumor initiation and aryl hydrocarbon hydroxylase. Cancer Res 1977; 37: 1631–5.
   PubMed Web of Science ®Google Scholar
• Prinz W, Bortz R, Bregin B, H ersch M. The effect of ascorbic acid supplementation on some parameters of the human im munological defense system. Int J V itam in Nutr Res 1977; 47: 248–57.
   Google Scholar
• Huwyler T, Hirt A, Morell A. Effect of ascorbic acid on hum an natural killer cells. Im m unol Lett 1985; 10: 173–6.
   PubMedGoogle Scholar
• Siegel BV, Morton JI. V itam in C and im munity: natural killer (NK) cell factor. Int J Vitam in Nutr Res 1983; 53: 179–83.
   PubMedGoogle Scholar
• Irw in MI, H utchins BK. A conspectus of research on vitamin C requirem ents of m an. J Nutr 1976; 106: 821–79.
   Google Scholar
• Roder JC, Pross HF. The biology of human natural killer cell. J Clin Im munol 1983; 2: 249–63.
   Google Scholar
• Jondal M. The hum an NK cellÐ a short over-view and an hypothesis on NK recognition. Clin Exp Im munol 1987; 70: 255–62.
   PubMedGoogle Scholar
• Nino HV, Prasad AS. V itamins and trace elem ents. In: Sonnenwirth AC, Jarett L, eds. Gradwohl’s Clinical Laboratory Methods and Diagnosis, V ol 1. Toronto, London: T he CV Mosby Com p, 1980: pp. 370–2.
   Google Scholar
• W hiteside TL, Bryant J, Day R, Herberman RB. Natural killer cytotoxicity in the diagnosis of imm une dysfunction: criteria for a reproducible assay. J Clin Lab Anal 1990; 4: 102–14.
   Google Scholar
• Fletcher MA, Baron GC, Ashman M, et al. Use of whole blood m ethods in assessment of imm une parameters in im munode®ciency states. Diagn Clin Imm unol 1987; 5: 69–81.
   PubMedGoogle Scholar
• Cameron E, Campbell A. The orthomolecular treatm ent of cancer. II Clinical trial of high-dose ascorbic supplements in advanced human cancer. Chem-Biol Interact 1974; 9: 285–315.
   Google Scholar
• Moertal CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients w ith advanced cancer w ho had no prior chem otherapy. New Eng J Med 1985; 312: 137–41.
   PubMedGoogle Scholar
• Helgestad J, Pettersen R, Strom-M athisen I, Schjerven L. Characterization of a new m alignant human T-cell line (PFI-285) sensitive to ascorbic acid. Eur J Haematol 1990; 44: 9–17.
   Google Scholar
• Siegel BV, Morton JI. V itam in C and im munity: in¯uence of ascorbate on prostaglandin E2 synthesis and implications for natural killer cell activity. Int J Vitamin Nutr Res 1984; 54: 339–42.
   PubMedGoogle Scholar
• Chandra RK. Effect of vitam in and trace-element supplementation on imm une responses and infection in elderly subjects. Lancet 1992; 340: 1124–7.
   PubMed Web of Science ®Google Scholar